Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

J&J's Medtech Business Is Soaring. Time to Buy the Stock?

TheMotleyFool

0 0

J&J's Medtech Business Is Soaring. Time to Buy the Stock?: https://g.foolcdn.com/editorial/images/741058/gettyimages-woman-points-at-computer-with-a-pen-to-show-something-to-a-colleague.jpg

You may not automatically think of pharma giant Johnson & Johnson (NYSE: JNJ) as a high-growth company. Yes, J&J is practically a household name, thanks to consumer products like Aveeno lotions and Band-Aid bandages. But these and other products haven't driven much growth over the past several years. And that may have pushed away some investors.

Things are changing at J&J though -- and a new era of growth might have already started. The star of the show? J&J's medtech business. It posted a double-digit increase in revenue in the second quarter. And more may be on the way.

Does this mean it's time to buy this big pharma stock? Let's find out.

Source Fool.com

Like: 0

JNJ

Share